scPharmaceuticals Inc. (NASDAQ:SCPH)’s quarterly earnings will be published on March, 19., according to Faxor. Analysts have expectation on stock’s EPS of $-0.44. That’s up 45.00 % from last year’s $-0.8 EPS. After $-0.31 EPS was published previous quarter, analysts now see negative EPS growth of 41.94 % for scPharmaceuticals Inc.. The stock decreased 1.53% or $0.05 during the last trading session, hitting $3.22.scPharmaceuticals Inc. has volume of 20,992 shares. Since February 28, 2018 SCPH has declined 66.67% and is downtrending. SCPH underperformed by 66.67% the S&P 500.

scPharmaceuticals Inc., a clinical-stage pharmaceutical company, engages in the development and commercialization of various pharmaceutical products.The company has $59.79 million market cap. The company's lead product candidate is Furoscix, a drug-device combination product that is under development for treatment of worsening or decompensated heart failure outside of the inpatient setting.Last it reported negative earnings. The Company’s product pipeline also includes scFurosemide, a loop diuretic for the management of edema in patients with decompensated heart failure; scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms.

For more scPharmaceuticals Inc. (NASDAQ:SCPH) news brought out recently go to: Seekingalpha.com, Benzinga.com, Seekingalpha.com, Benzinga.com or Globenewswire.com. The titles are as follows: “ScPharmaceuticals down 19% – Seeking Alpha” brought out on November 16, 2018, “Daily Biotech Pulse: Acorda Swings To Profit, Achaogen Offering, Bioblast Strikes Sanfilippo Syndrome Deal – Benzinga” on February 15, 2019, “Allergan downgraded on soft 2019 guidance in premarket analyst action – Seeking Alpha” with a publish date: January 30, 2019, “Benzinga’s Top Upgrades, Downgrades For January 30, 2019 – Benzinga” and the last “scPharmaceuticals Inc. Provides Regulatory Update on FUROSCIX® – GlobeNewswire” with publication date: October 18, 2018.